ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,992, issued on Sept. 22, was assigned to Roche Diagnostics Operations Inc. (Indianapolis). "Bacterial pilus protein complex FIMGT-DSF stab... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,993, issued on Sept. 22, was assigned to DANISCO US INC. (Palo Alto, Calif.). "Methods and compositions for producing proteins of interest... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,994, issued on Sept. 22, was assigned to KYOTO PREFECTURAL PUBLIC UNIVERSITY Corp. (Kyoto, Japan) and KYOTO SANGYO UNIVERSITY (Kyoto, Japan... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,995, issued on Sept. 22, was assigned to Integrated DNA Technologies Inc. (Coralville, Iowa). "Ubiquitin variant with high affinity for bi... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,996, issued on Sept. 22, was assigned to The Regents of the University of California (Oakland, Calif.). "Modulation of Wnt5a to treat glau... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,997, issued on Sept. 22, was assigned to Massachusetts Institute of Technology (Cambridge, Mass.). "Selective MCL-1 binding peptides" was ... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,998, issued on Sept. 22, was assigned to VIB VZW (Ghent, Belgium), UNIVERSITEIT GENT (Ghent, Belgium), CENTRE NATIONAL DE LA RECHERCHE SCIE... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,741,999, issued on Sept. 22, was assigned to ELI LILLY AND COMPANY (Indianapolis). "Incretin analogs and uses thereof" was invented by Jorge A... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,000, issued on Sept. 22, was assigned to Akston Biosciences Corp. (Beverly, Mass.). "Insulin-Fc fusion proteins and methods of use to trea... Read More
ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,001, issued on Sept. 22, was assigned to ST. JUDE CHILDREN'S RESEARCH HOSPITAL INC. (Memphis, Tenn.). "Chimeric antigen receptors with CD2... Read More